Skip to main content
letter
. 2020 Oct 15;202(8):1173–1178. doi: 10.1164/rccm.202005-1582LE

Table 1.

Baseline Characteristics, Treatments, and Main Outcomes of Included Patients

Demographic data  
 Age, yr 66 (57–73)
 Sex, M 22 (78.6)
Comorbidities  
 Any 25 (89)
 ≥3 11 (39)
 Arterial hypertension 20 (71)
 Diabetes 5 (18)
 BMI >25 kg/m2 9 (32)
 Obstructive sleep apnea 7 (25)
 Chronic obstructive pulmonary disease 4 (14)
 Coronary heart disease 3 (11)
 Chronic kidney disease 2 (7)
 Malignancy 3 (11)
Time from onset of symptoms to  
 ICU admission, d 8 (5–11)
 Invasive mechanical ventilation, d 9 (5–11)
SAPS II score at admission 59 (39–65)
SOFA score at admission 7 (4–9)
Minimal PaO2/FiO2 ratio, mm Hg 110 (98–128)
Mild ARDS 1 (4)
Moderate ARDS 19 (68)
Severe ARDS 8 (29)
Treatments for ARDS  
 Continuous infusion of neuromuscular blockers 24 (86)
 Prone position 19 (68)
 Inhaled nitric oxide 6 (21)
 Almitrine infusion 2 (7)
 Extracorporeal membrane oxygenation 1 (4)
Outcomes  
 VFD at Day 30 0 (0–5)
 Weaning before Day 30 11 (39)
 Tracheostomy 17 (61)
 Renal replacement therapy 2 (7)
 Discharge from ICU before Day 30 11 (39)
 30-d mortality 1 (4)

Definition of abbreviations: ARDS = acute respiratory distress syndrome; BMI = body mass index; SAPS II = Simplified Acute Physiology Score; SOFA = Sequential Organ Failure Assessment; VFD = ventilator-free days.

n = 28. Data are expressed as n (%) or median (interquartile range).